C178H150F6N22O10S — CID 159970928
N-[5-(2-methoxyphenyl)-2-pyridinyl]-2-[4-(2-methyl-4-pyridinyl)phenyl]acetamide;N-[5-(3-methoxyphenyl)-2-pyridinyl]-2-[4-(2-methyl-4-pyridinyl)phenyl]acetamide;N-[5-(4-methoxyphenyl)-2-pyridinyl]-2-[4-(2-methyl-4-pyridinyl)phenyl]acetamide;N-[5-(3-methylphenyl)-2-pyridinyl]-2-[4-(2-methyl-4-pyridinyl)phenyl]acetamide;2-[4-(2-methyl-4-pyridinyl)phenyl]-N-(5-phenylpyrazin-2-yl)acetamide;2-[4-(2-methyl-4-pyridinyl)-3-(trifluoromethyl)phenyl]-N-(5-phenyl-2-pyridinyl)acetamide;2-[4-(2-methyl-4-pyridinyl)-3-(trifluoromethyl)phenyl]-N-(4-phenyl-1,3-thiazol-2-yl)acetamide (PubChem CID 159970928) has the molecular formula C178H150F6N22O10S and a molecular weight of 2903.36 g/mol. Its IUPAC name is N-[5-(2-methoxyphenyl)-2-pyridinyl]-2-[4-(2-methyl-4-pyridinyl)phenyl]acetamide;N-[5-(3-methoxyphenyl)-2-pyridinyl]-2-[4-(2-methyl-4-pyridinyl)phenyl]acetamide;N-[5-(4-methoxyphenyl)-2-pyridinyl]-2-[4-(2-methyl-4-pyridinyl)phenyl]acetamide;N-[5-(3-methylphenyl)-2-pyridinyl]-2-[4-(2-methyl-4-pyridinyl)phenyl]acetamide;2-[4-(2-methyl-4-pyridinyl)phenyl]-N-(5-phenylpyrazin-2-yl)acetamide;2-[4-(2-methyl-4-pyridinyl)-3-(trifluoromethyl)phenyl]-N-(5-phenyl-2-pyridinyl)acetamide;2-[4-(2-methyl-4-pyridinyl)-3-(trifluoromethyl)phenyl]-N-(4-phenyl-1,3-thiazol-2-yl)acetamide.
| Compound Name | N-[5-(2-methoxyphenyl)-2-pyridinyl]-2-[4-(2-methyl-4-pyridinyl)phenyl]acetamide;N-[5-(3-methoxyphenyl)-2-pyridinyl]-2-[4-(2-methyl-4-pyridinyl)phenyl]acetamide;N-[5-(4-methoxyphenyl)-2-pyridinyl]-2-[4-(2-methyl-4-pyridinyl)phenyl]acetamide;N-[5-(3-methylphenyl)-2-pyridinyl]-2-[4-(2-methyl-4-pyridinyl)phenyl]acetamide;2-[4-(2-methyl-4-pyridinyl)phenyl]-N-(5-phenylpyrazin-2-yl)acetamide;2-[4-(2-methyl-4-pyridinyl)-3-(trifluoromethyl)phenyl]-N-(5-phenyl-2-pyridinyl)acetamide;2-[4-(2-methyl-4-pyridinyl)-3-(trifluoromethyl)phenyl]-N-(4-phenyl-1,3-thiazol-2-yl)acetamide |
|---|---|
| PubChem CID | 159970928 |
| Molecular Formula | C178H150F6N22O10S |
| Molecular Weight | 2903.36 g/mol |
| Exact Mass | 2901.15 |
| IUPAC Name | N-[5-(2-methoxyphenyl)-2-pyridinyl]-2-[4-(2-methyl-4-pyridinyl)phenyl]acetamide;N-[5-(3-methoxyphenyl)-2-pyridinyl]-2-[4-(2-methyl-4-pyridinyl)phenyl]acetamide;N-[5-(4-methoxyphenyl)-2-pyridinyl]-2-[4-(2-methyl-4-pyridinyl)phenyl]acetamide;N-[5-(3-methylphenyl)-2-pyridinyl]-2-[4-(2-methyl-4-pyridinyl)phenyl]acetamide;2-[4-(2-methyl-4-pyridinyl)phenyl]-N-(5-phenylpyrazin-2-yl)acetamide;2-[4-(2-methyl-4-pyridinyl)-3-(trifluoromethyl)phenyl]-N-(5-phenyl-2-pyridinyl)acetamide;2-[4-(2-methyl-4-pyridinyl)-3-(trifluoromethyl)phenyl]-N-(4-phenyl-1,3-thiazol-2-yl)acetamide |
| SMILES | COc1ccc(-c2ccc(NC(=O)Cc3ccc(-c4ccnc(C)c4)cc3)nc2)cc1.COc1cccc(-c2ccc(NC(=O)Cc3ccc(-c4ccnc(C)c4)cc3)nc2)c1.COc1ccccc1-c1ccc(NC(=O)Cc2ccc(-c3ccnc(C)c3)cc2)nc1.Cc1cc(-c2ccc(CC(=O)Nc3ccc(-c4ccccc4)cn3)cc2C(F)(F)F)ccn1.Cc1cc(-c2ccc(CC(=O)Nc3cnc(-c4ccccc4)cn3)cc2)ccn1.Cc1cc(-c2ccc(CC(=O)Nc3nc(-c4ccccc4)cs3)cc2C(F)(F)F)ccn1.Cc1cccc(-c2ccc(NC(=O)Cc3ccc(-c4ccnc(C)c4)cc3)nc2)c1 |
| InChI | InChI=1S/C26H20F3N3O.3C26H23N3O2.C26H23N3O.C24H18F3N3OS.C24H20N4O/c1-17-13-20(11-12-30-17)22-9-7-18(14-23(22)26(27,28)29)15-25(33)32-24-10-8-21(16-31-24)19-5-3-2-4-6-19;1-18-15-22(13-14-27-18)20-5-3-19(4-6-20)16-26(30)29-25-12-9-23(17-28-25)21-7-10-24(31-2)11-8-21;1-18-14-22(12-13-27-18)20-8-6-19(7-9-20)15-26(30)29-25-11-10-23(17-28-25)21-4-3-5-24(16-21)31-2;1-18-15-21(13-14-27-18)20-9-7-19(8-10-20)16-26(30)29-25-12-11-22(17-28-25)23-5-3-4-6-24(23)31-2;1-18-4-3-5-22(14-18)24-10-11-25(28-17-24)29-26(30)16-20-6-8-21(9-7-20)23-12-13-27-19(2)15-23;1-15-11-18(9-10-28-15)19-8-7-16(12-20(19)24(25,26)27)13-22(31)30-23-29-21(14-32-23)17-5-3-2-4-6-17;1-17-13-21(11-12-25-17)19-9-7-18(8-10-19)14-24(29)28-23-16-26-22(15-27-23)20-5-3-2-4-6-20/h2-14,16H,15H2,1H3,(H,31,32,33);3-15,17H,16H2,1-2H3,(H,28,29,30);3-14,16-17H,15H2,1-2H3,(H,28,29,30);3-15,17H,16H2,1-2H3,(H,28,29,30);3-15,17H,16H2,1-2H3,(H,28,29,30);2-12,14H,13H2,1H3,(H,29,30,31);2-13,15-16H,14H2,1H3,(H,27,28,29) |
| InChIKey | OENPXOXYDRGEGX-UHFFFAOYSA-N |
| XLogP | 38.93 |
| TPSA | 424.74 Ų |
| H-Bond Donors | 7 |
| H-Bond Acceptors | 26 |
| Rotatable Bonds | 38 |
| Heavy Atoms | 217 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2903.36 |
| LogP ≤ 5 | 38.93 |
| H-Bond Donors ≤ 5 | 7 |
| H-Bond Acceptors ≤ 10 | 26 |